ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Field Medical Director at Annexon Biosciences - ApplyBlast

Field Medical Director

Annexon Biosciences

3 months ago

3.5 on Glassdoor

San Francisco, California, United States

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Field Medical Director at Annexon Biosciences will serve as a medical expert and extension of the Medical Affairs team, building and maintaining relationships with thought leaders, investigators, and key stakeholders across the Southeast region. The role focuses on scientific exchange, supporting clinical development, and delivering education on Annexon's ophthalmologic products and pipeline.

Responsibilities

Develop and maintain professional relationships with thought leaders
Collaborate on research projects, advisory boards, and publications
Deliver scientific education to payers, formulary committees, and patient groups
Support clinical trial site identification and patient recruitment activities
Ensure compliant collaboration with cross‑functional field partners

Skills

Qualifications

PharmDPhDMDDO

About Annexon Biosciences

annexonbio.com

Headquarters

South San Francisco, California, United States

Company Size

51-200 employees

Founded

2011

View Profile

Annexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.